Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
New clinical trial design in precision medicine: discovery, development and direction
XP Duan, BD Qin, XD Jiao, K Liu, Z Wang… - Signal Transduction and …, 2024 - nature.com
In the era of precision medicine, it has been increasingly recognized that individuals with a
certain disease are complex and different from each other. Due to the underestimation of the …
certain disease are complex and different from each other. Due to the underestimation of the …
Mesothelioma: Scientific clues for prevention, diagnosis, and therapy
Mesothelioma affects mostly older individuals who have been occupationally exposed to
asbestos. The global mesothelioma incidence and mortality rates are unknown, because …
asbestos. The global mesothelioma incidence and mortality rates are unknown, because …
Integrative molecular characterization of malignant pleural mesothelioma
Malignant pleural mesothelioma (MPM) is a highly lethal cancer of the lining of the chest
cavity. To expand our understanding of MPM, we conducted a comprehensive integrated …
cavity. To expand our understanding of MPM, we conducted a comprehensive integrated …
ALK fusions in the pan-cancer setting: another tumor-agnostic target?
Anaplastic lymphoma kinase (ALK) alterations (activating mutations, amplifications, and
fusions/rearrangements) occur in~ 3.3% of cancers. ALK fusions/rearrangements are …
fusions/rearrangements) occur in~ 3.3% of cancers. ALK fusions/rearrangements are …
[HTML][HTML] Pleural mesothelioma classification—update and challenges
S Dacic - Modern Pathology, 2022 - Elsevier
Mesothelial tumors are classified into benign or preinvasive tumors, and mesotheliomas.
The benign or preinvasive group includes adenomatoid tumors, well-differentiated papillary …
The benign or preinvasive group includes adenomatoid tumors, well-differentiated papillary …
New era for malignant pleural mesothelioma: updates on therapeutic options
AS Tsao, HI Pass, A Rimner… - Journal of Clinical …, 2022 - ascopubs.org
Malignant pleural mesothelioma (MPM) is a rare malignancy with few treatment options.
Recent advances have led to US Food and Drug Administration approvals and changes in …
Recent advances have led to US Food and Drug Administration approvals and changes in …
[PDF][PDF] Guidelines for pathologic diagnosis of mesothelioma: 2023 update of the consensus statement from the international mesothelioma interest group
AN Husain, DB Chapel, R Attanoos… - … of Pathology & …, 2024 - meridian.allenpress.com
Context.—Mesothelioma is an uncommon tumor that can be difficult to diagnose. Objective.—
To provide updated, practical guidelines for the pathologic diagnosis of mesothelioma. Data …
To provide updated, practical guidelines for the pathologic diagnosis of mesothelioma. Data …
[HTML][HTML] Second Paediatric Strategy Forum for anaplastic lymphoma kinase (ALK) inhibition in paediatric malignancies: ACCELERATE in collaboration with the …
Abstract The first (2017) and sixth (2021) multistakeholder Paediatric Strategy Forums
focused on anaplastic lymphoma kinase (ALK) inhibition in paediatric malignancies. ALK is …
focused on anaplastic lymphoma kinase (ALK) inhibition in paediatric malignancies. ALK is …
Malignant peritoneal mesothelioma: a review
Malignant peritoneal mesothelioma (MPM) is a very rare malignancy of the peritoneum and
has a poor prognosis. Of all mesotheliomas, pleural mesothelioma is more common than …
has a poor prognosis. Of all mesotheliomas, pleural mesothelioma is more common than …
[HTML][HTML] Well-differentiated papillary mesothelioma of the peritoneum is genetically defined by mutually exclusive mutations in TRAF7 and CDC42
M Stevers, JT Rabban, K Garg, J Van Ziffle, C Onodera… - Modern Pathology, 2019 - Elsevier
Well-differentiated papillary mesothelioma is an uncommon mesothelial neoplasm that most
frequently arises in the peritoneal cavity of women of reproductive age. Whereas malignant …
frequently arises in the peritoneal cavity of women of reproductive age. Whereas malignant …